Quantitative Movement Testing: Measuring Patient Movements from a Single Smartphone Video

Researchers developed Quantitative Movement Testing (QMT), a computer vision system that measures patient movement from smartphone videos with clinical-grade accuracy. The technology uses deep learning-based 3D pose estimation to extract kinematic biomarkers, validated against optical motion capture in lab settings and tested in real-world chronic pain studies.

QMT addresses a critical gap in clinical medicine: the inability to objectively measure functional decline from chronic pain outside controlled laboratory environments. Traditional optical motion capture systems cost tens of thousands of dollars and require dedicated lab facilities, making longitudinal monitoring of chronic conditions impractical for most patients. This research demonstrates that monocular smartphone video combined with modern pose-estimation algorithms can achieve comparable accuracy (r > 0.85 correlations, strong test-retest reliability) while eliminating infrastructure barriers.

The validation pipeline is methodologically rigorous, using leave-one-subject-out calibration to correct systematic bias and testing across multiple real-world scenarios—fibromyalgia interventions and 30-day home monitoring of sciatica patients. Results show the system successfully identified group-level differences between healthy controls and chronic pain patients using only remote recordings, proving clinical utility beyond laboratory conditions.

This advancement carries significant implications for digital health and remote patient monitoring markets. Healthcare systems can now conduct objective movement assessments at scale without expensive equipment or patient travel, reducing friction in chronic disease management and clinical trial recruitment. The technology particularly benefits underserved populations with mobility limitations who cannot easily visit specialized facilities.

Future development should focus on improving reliability in uncontrolled home environments, where measurement variance increased compared to lab settings. Integration with wearable sensors and longitudinal AI models could further enhance predictive capability for treatment response. The commercialization pathway through digital health platforms and telehealth providers represents a substantial market opportunity.

• →QMT enables clinical-grade movement analysis from smartphone video, eliminating expensive optical motion capture infrastructure requirements.
• →Validation against gold-standard motion capture achieved strong correlations (r > 0.85) and high test-retest reliability in clinical populations.
• →System successfully tracked disease progression and treatment response in real-world home settings despite higher measurement variance than lab conditions.
• →Technology addresses major accessibility barrier in chronic pain management by enabling remote, objective functional assessment.
• →Further optimization needed for home environment reliability before widespread clinical deployment.